Table 2.
Biopsy specimen |
Hysterectomy specimen |
Traditional reported values from literature | |||
---|---|---|---|---|---|
#stained | %positive | #stained | %positive | ||
P-AKT+ | 13/19 | 68% | 11/24 | 46% | 20–42%(Network et al., 2013) |
ER+ | 15/21 | 71% | 15/24 | 63% | 19–44%(Kuderer et al., 2017; Wolff et al., 2013) |
PR+ | 9/20 | 45% | 10/24 | 42% | 19–24%(Mentrikoski and Stoler, 2014) |
EGFR+ | 9/20 | 45% | 5/20 | 75% | 50–80%(Buza et al., 2013) |
Her2/neu+ | 20/20 | 100% | 25/25 | 100% | 18–80%(Del Carmen and Rice, 2017; Mentrikoski and Stoler, 2014; Fader et al., 2018; Network et al., 2013) |
Loss of PTEN | 0/19 | 0% | 0/24 | 0% | 0–11%(Mentrikoski and Stoler, 2014; Network et al., 2013) |